Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer

Sebastian Strieth*, Christoph Dunau, Uwe Michaelis, Lorenz Jäger, Donata Gellrich, Barbara Wollenberg, Marc Dellian

*Corresponding author for this work
28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences